Genomics Industry Market Research Reports in the United States, May 2013

You might be interested in: genetic, molecular biology, genome sequencing, more »

» Download Public Reports

1-30 of about 500 reports
Company Report: Genomics in The United States for Year 2012

Company Report: Genomics in The United States for Year 2012

  • Company report
  • September 2012
  • 43 pages

  • Industries: Genomics
  • Countries: United States
Genomics Collaborative Inc. - Investment Analysis, November 2012

Genomics Collaborative Inc. - Investment Analysis, November 2012

  • Company report
  • November 2012
  • 5 pages

... Contained in our forward-looking statements, whether as a result of new information, future events or otherwise. Complete genomics, inc. Condensed consold statements of comprehensive loss (in thousands ...

  • Industries: Genomics
  • Countries: United States
Company Report: Genomics in The United States for Year 2012

Company Report: Genomics in The United States for Year 2012

  • Company report
  • November 2012
  • 175 pages

... Of financial results for the full year or any other interim period. The company operates as one segment, providing whole human genome sequencing and analysis. The condensed consold financial statements ...

  • Industries: Genomics
  • Countries: United States
Genomics Collaborative Inc. - Company Report for Year 2012

Genomics Collaborative Inc. - Company Report for Year 2012

  • Company report
  • September 2012
  • 51 pages
  • by Corporation

... Of complete genomics, inc., A delaware corporation (the Company ), At a purchase price of $3.15 Per share, net to the seller in cash, without interest thereon, less any required withholding taxes, upon ...

  • Industries: Genomics
  • Countries: United States
Genomics Collaborative Inc. - Company Report for Year 2012

Genomics Collaborative Inc. - Company Report for Year 2012

  • Company report
  • September 2012
  • 64 pages
  • by Corporation

... Of complete genomics, inc., A delaware corporation (the Company ), At a purchase price of $3.15 Per share, net to the seller in cash, without interest thereon, less any required withholding taxes, upon ...

  • Industries: Genomics
  • Countries: United States
Illumina Inc. - Annual Report 2012

Illumina Inc. - Annual Report 2012

  • Company report
  • October 2012
  • 23 pages

... Breakthrough turnaround time, available via illumina's clia-certified laboratory Announced an alliance with partners healthcare to introduce next-generation sequencing (ngs) clinical interpretation ...

  • Industries: Genomics
  • Countries: United States
Company Report: Genomics in The United States and China for Year 2012

Company Report: Genomics in The United States and China for Year 2012

  • Company report
  • September 2012
  • 90 pages
  • by Corporation

... On the opportunities and risks associated with: the company S business and financial condition; the rapidly changing technologies, demand and competition for whole human genome sequencing; and possible sources ...

  • Industries: Genomics
  • Countries: United States, China
Company Report: Genomics in The United States for Year 2012

Company Report: Genomics in The United States for Year 2012

  • Company report
  • September 2012
  • 3 pages
  • by Research Paper

... Of diseases. microrna S big role according to the filing, Micrornas are recently discovered, naturally occurring ribonucleic acid, or rna, molecules that play a critical role in regulating key biological ...

  • Industries: Genomics
  • Countries: United States
Company Report: Genomics in Sweden, The United States and Egypt for Year 2012

Company Report: Genomics in Sweden, The United States and Egypt for Year 2012

  • Company report
  • August 2012
  • 7 pages

... Stage, already accomplished and consistent with the mandate, signature dna is on the microchips produced in the dla S generalized emulation of microcircuits program, known as gem. In the mandated ...

  • Industries: Genomics
  • Countries: Sweden, United States, Egypt
Company Report: Genomics in The United States and Switzerland for Year 2013

Company Report: Genomics in The United States and Switzerland for Year 2013

  • Company report
  • March 2013
  • 10 pages
  • by Corporation

  • Industries: Genomics
  • Countries: United States, Switzerland
Company Report: Genomics in The United States and Israel for Year 2012

Company Report: Genomics in The United States and Israel for Year 2012

  • Company report
  • August 2012
  • 82 pages

... microrna field, and that as a result, we have developed an early and strong intellectual property position related to the development and commercialization of microrna-based diagnostics. Using our ...

  • Industries: Genomics
  • Countries: United States, Israel
Genomics Collaborative Inc. - Company Report for Year 2013

Genomics Collaborative Inc. - Company Report for Year 2013

  • Company report
  • March 2013
  • 28 pages
  • by Corporation

... Bgi-shenzhen completes acquisition of complete genomics combined company to focus on high volume, accurate human genomic sequencing and accelerating the spread of genomic medicine shenzhen, china ...

  • Industries: Genomics
  • Countries: United States
Company Report: Genome Sequencing in The United States for Year 2012

Company Report: Genome Sequencing in The United States for Year 2012

  • Company report
  • August 2012
  • 3 pages

... Addressing the privacy of human genome sequence data. Some of the recommendations may impact non-profit organizations that fund genomic research, such as research foundations, institutes and patient advocacy ...

  • Industries: Genomics
  • Countries: United States
Summit Resources - Company Report for Year 2012

Summit Resources - Company Report for Year 2012

  • Company report
  • December 2012
  • 178 pages

... In pharmaceutical research, as well as many other fields, including agriculture, pathology, biomarker discovery, biodefense and forensics. Laesi is intended to meet the broad need of the biologist for the direct ...

  • Industries: Genomics
  • Countries: United States
Genomics in The United States : Innovation and Technology Trends

Genomics in The United States : Innovation and Technology Trends

  • Industry report
  • September 2012
  • 51 pages

  • Industries: Genomics
  • Countries: United States, World, Europe
Genomics Market in The United States

Genomics Market in The United States

  • Industry report
  • August 2012
  • 8 pages

... Mg of m-mulv protein as described previously (7). The deproteinized rna was purified further by a second sodium dodecyl sulfate (sds)-sucrose gradient cen- trifugation, recovered by ethanol ...

  • Industries: Genomics
  • Countries: United States
Genomics Industry  in The United States, Israel and Greece

Genomics Industry in The United States, Israel and Greece

  • Industry report
  • August 2012
  • 19 pages

... And execution expertise rosetta S microrna advantage: micrornas are acknowledged as outstanding biomarkers: master gene regulators, highly tissue specific, in most major diseases and extremely stable ...

  • Industries: Genomics
  • Countries: United States, Israel, Greece
U.S. Genomics Industry : Innovation and Technology Trends

U.S. Genomics Industry : Innovation and Technology Trends

  • Industry report
  • August 2012
  • 17 pages

... pharmacogenomics and pharmacogenetics are a growing phenomenon and as such over xxx publically funded research organisations worldwide are currently investigating personalized medicine as a plausible cand ...

  • Industries: Genomics
  • Countries: Europe, United States, World
Genomics in The United States : Innovation and Technology Trends

Genomics in The United States : Innovation and Technology Trends

  • Industry report
  • November 2012
  • 6 pages

... Unpublished data Waiting on patents) now hiring a senior scientist in computational biology to join the grassroots computational gene regulation engineering team gfp expression in root tip, driven ...

  • Industries: Genomics
  • Countries: United States
Genetic Market in The United States

Genetic Market in The United States

  • Industry report
  • January 2013
  • 35 pages

... Of the 63 respondents that have an ehr, 65% report ability to easily & efficiently capture genetics information and fh as fair or poor 12 results Incentives 0% 50% 100% easier access ...

  • Industries: Genomics
  • Countries: United States
Agriculture and Genomics in The United Kingdom and The United States : Innovation and Technology Trends

Agriculture and Genomics in The United Kingdom and The United States : Innovation and Technology Trends

  • Industry report
  • January 2013
  • 33 pages

... Systems approaches to crop improvement Modelling wp1 wp2 wp3 wp4 where knowledge grows rothamsted research key objectives Exploit variation and biotechnology to increase biomass (nue ...

  • Industries: Agriculture, Genomics
  • Countries: United Kingdom, World, United States
U.S. Genomics Business : Innovation and Technology Trends

U.S. Genomics Business : Innovation and Technology Trends

  • Industry report
  • March 2013
  • 47 pages

... Useful database systems; private and public advances in new technologies as high throughput next generation sequencing availability of numerous helpful software tools fragmented, in some ...

  • Industries: Genomics
  • Countries: United States
U.S. Biomarker Market : Innovation and Technology Trends

U.S. Biomarker Market : Innovation and Technology Trends

  • Industry report
  • April 2013
  • 25 pages

... Recruitment biomarker discovery biomarker validation clinical validation Second most frequent cancer in the developed world Current tests low specificity and poor patient compliance Ogt ...

  • Industries: Genomics
  • Countries: World, United States
Personal Genomics Sector in The United States

Personal Genomics Sector in The United States

  • Industry report
  • December 2012
  • 16 pages

... Medicine (pm) based on personal genome to revolu- tionize the next generation healthcare. Diagnomics applies modern genomics technologies to the development of pro- ducts and services that translate ...

  • Industries: Genomics
  • Countries: United States
Genomics Sector in The United States

Genomics Sector in The United States

  • Industry report
  • November 2012
  • 46 pages

... Select superior animals as parents of future generations phenotyp e pedigree statistical methodology predicted genetic merit genetic evaluations - limitations Slow Progeny testing for production ...

  • Industries: Genomics
  • Countries: United States
Genomics Market Analysis in The United States

Genomics Market Analysis in The United States

  • Industry report
  • October 2012
  • 90 pages

  • Industries: Genomics
  • Countries: United States
Genomics in Qatar and The United States : Innovation and Technology Trends

Genomics in Qatar and The United States : Innovation and Technology Trends

  • Industry report
  • April 2013
  • 35 pages

... By organizing different workshops on cellular and molecular biology assays in order to explore the effect of physical and chemical agents on human dna by analysing chromosomal alterations. Why 1. Dna ...

  • Industries: Genomics
  • Countries: Qatar, United States
Dna Sequencing Sector in The United States

Dna Sequencing Sector in The United States

  • Industry report
  • November 2012
  • 20 pages
  • by Intergovernmental Agency

... Are dna Recombinant dna sequencing dna Automation Scale-up shared features: rapidly accelerating power, drop in price. Ubiquity. Pervasiveness. Disruption. Unanticipated uses. Network ...

  • Industries: Genomics
  • Countries: United States
Genomics Sector in The United States

Genomics Sector in The United States

  • Industry report
  • November 2012
  • 24 pages

... Which to recoup testing costs. N need to capture the cumulative supply chain value derived from using genomics for multiple purposes (selection, parentage, genetic defects, marker-assisted management ...

  • Industries: Genomics
  • Countries: United States
Biomarker Market in The United States

Biomarker Market in The United States

  • Industry report
  • October 2012
  • 42 pages

  • Industries: Genomics
  • Countries: United States

» Purchase Premium Reports (From $ 125 - $ 2 795)

About 200 reports
Pharmacogenomics Partnering Terms and Agreements

Pharmacogenomics Partnering Terms and Agreements

  • $ 2 795
  • Industry report
  • April 2013
  • by Currentpartnering

The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds ...


» Read our Company Profiles

2 Companies

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.